Overview
Christopher Daugherty is an Oncologist practicing medicine in Chicago, Illinois.
Dr. Daugherty is highly rated in 5 conditions, according to our data. His clinical expertise encompasses Sickle Cell Disease, RUNX1 Familial Platelet Disorder, Paris-Trousseau Thrombocytopenia, Bone Marrow Aspiration, and Gastrostomy.
He is actively involved in clinical research, co-authoring 27 peer reviewed articles and participating in 1 clinical trial.
Specialties
Licenses
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- PPO
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
- MEDICARE MAPD
- MEDICARE SNP
Locations
5841 S Maryland Ave, Chicago, IL 60637
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
University Of Chicago Medical Center
Sonali Smith is an Oncologist practicing medicine in Chicago, Illinois. Dr. Smith is highly rated in 28 conditions, according to our data. Her clinical expertise encompasses Non-Hodgkin Lymphoma, Follicular Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Bone Marrow Transplant, and Bone Marrow Aspiration.
Leo Gordon is a Hematologist and an Oncologist practicing medicine in Chicago, Illinois. He has been practicing medicine for over 53 years. Dr. Gordon is highly rated in 33 conditions, according to our data. His clinical expertise encompasses Non-Hodgkin Lymphoma, Hodgkin Lymphoma, B-Cell Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Gordon is board certified in American Board Of Internal Medicine - Hematology (Certified).
Jessica Altman is a Hematologist and an Oncologist practicing medicine in Chicago, Illinois. She has been practicing medicine for over 25 years. Dr. Altman is highly rated in 17 conditions, according to our data. Her clinical expertise encompasses Acute Myeloid Leukemia (AML), Leukemia, Acute Promyelocytic Leukemia, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Altman is board certified in American Board Of Internal Medicine - Hematology (Certified).
Frequently Asked Questions about Dr. Christopher Daugherty
How do I make an appointment with Dr. Christopher Daugherty?
You can book an appointment with Dr. Christopher Daugherty by calling their office at 773-702-6149. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Christopher Daugherty a top-rated expert for Sickle Cell Disease?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Christopher Daugherty is classified as an Advanced expert for Sickle Cell Disease, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Christopher Daugherty specialize in?
While Dr. Christopher Daugherty is a Oncology, they have specific expertise in Sickle Cell Disease, RUNX1 Familial Platelet Disorder, and Paris-Trousseau Thrombocytopenia. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.
Does Dr. Christopher Daugherty participate in research or clinical trials?
Yes. Dr. Christopher Daugherty has published 27 articles and abstracts on conditions like Sickle Cell Disease. You can view a list of Dr. Christopher Daugherty's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Christopher Daugherty accept my insurance?
Dr. Christopher Daugherty accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 773-702-6149 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Monoclonal Gammopathy of Undetermined Significance (MGUS)
- Paris-Trousseau ThrombocytopeniaDr. Daugherty isAdvanced. Learn about Paris-Trousseau Thrombocytopenia.
- RUNX1 Familial Platelet DisorderDr. Daugherty isAdvanced. Learn about RUNX1 Familial Platelet Disorder.
- Schnitzler SyndromeDr. Daugherty isAdvanced. Learn about Schnitzler Syndrome.
- Sickle Cell DiseaseDr. Daugherty isAdvanced. Learn about Sickle Cell Disease.
- Experienced
- Acute Lymphoblastic Leukemia (ALL)Dr. Daugherty isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Acute Myeloblastic Leukemia with MaturationDr. Daugherty isExperienced. Learn about Acute Myeloblastic Leukemia with Maturation.
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Daugherty isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Acute Myelomonocytic LeukemiaDr. Daugherty isExperienced. Learn about Acute Myelomonocytic Leukemia.
- Adult Immune ThrombocytopeniaDr. Daugherty isExperienced. Learn about Adult Immune Thrombocytopenia.